David Mole
David Mole
Professor of Renal Medicine, University of Oxford
Verified email at well.ox.ac.uk
Title
Cited by
Cited by
Year
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola, DR Mole, YM Tian, MI Wilson, J Gielbert, SJ Gaskell, ...
Science 292 (5516), 468-472, 2001
53022001
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein, JM Gleadle, LA McNeill, KS Hewitson, J O'Rourke, DR Mole, ...
Cell 107 (1), 43-54, 2001
33702001
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman, N Masson, DR Mole, P Jaakkola, GW Chang, SC Clifford, ...
Journal of Biological Chemistry 275 (33), 25733-25741, 2000
12072000
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability
JS Isaacs, YJ Jung, DR Mole, S Lee, C Torres-Cabala, YL Chung, ...
Cancer cell 8 (2), 143-153, 2005
8652005
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
J Schödel, S Oikonomopoulos, J Ragoussis, CW Pugh, PJ Ratcliffe, ...
Blood, The Journal of the American Society of Hematology 117 (23), e207-e217, 2011
5212011
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
SO Ang, H Chen, K Hirota, VR Gordeuk, J Jelinek, Y Guan, E Liu, ...
Nature genetics 32 (4), 614-621, 2002
5202002
Genome-wide association of hypoxia-inducible factor (HIF)-1α and HIF-2α DNA binding with expression profiling of hypoxia-inducible transcripts
DR Mole, C Blancher, RR Copley, PJ Pollard, JM Gleadle, J Ragoussis, ...
Journal of biological chemistry 284 (25), 16767-16775, 2009
5082009
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford, ME Cockman, AC Smallwood, DR Mole, ER Woodward, ...
Human molecular genetics 10 (10), 1029-1038, 2001
4032001
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
PJ Pollard, C Loenarz, DR Mole, MA McDonough, JM Gleadle, ...
Biochemical Journal 416 (3), 387-394, 2008
2692008
Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival
H Choudhry, A Albukhari, M Morotti, S Haider, D Moralli, J Smythies, ...
Oncogene 34 (34), 4482-4490, 2015
2232015
The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia insights into cellular transformation processes mediated by HIF-1
R Schietke, C Warnecke, I Wacker, J Schödel, DR Mole, V Campean, ...
Journal of Biological Chemistry 285 (9), 6658-6669, 2010
2132010
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase
DR Mole, I Schlemminger, LA McNeill, KS Hewitson, CW Pugh, ...
Bioorganic & medicinal chemistry letters 13 (16), 2677-2680, 2003
1562003
Common genetic variants at the 11q13. 3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
J Schödel, C Bardella, LK Sciesielski, JM Brown, CW Pugh, V Buckle, ...
Nature genetics 44 (4), 420-425, 2012
1332012
Hypoxia, hypoxia-inducible transcription factors, and renal cancer
J Schödel, S Grampp, ER Maher, H Moch, PJ Ratcliffe, P Russo, DR Mole
European urology 69 (4), 646-657, 2016
1312016
Determination and comparison of specific activity of the HIF-prolyl hydroxylases
JR Tuckerman, Y Zhao, KS Hewitson, YM Tian, CW Pugh, PJ Ratcliffe, ...
FEBS letters 576 (1-2), 145-150, 2004
1262004
Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1 α, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases
HJ Knowles, YM Tian, DR Mole, AL Harris
Circulation research 95 (2), 162-169, 2004
1232004
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors NEW LINK BETWEEN HYPOXIA SIGNALING AND IRON HOMEOSTASIS
S Lakhal, J Schödel, ARM Townsend, CW Pugh, PJ Ratcliffe, DR Mole
Journal of Biological Chemistry 286 (6), 4090-4097, 2011
1192011
Regulation of HIF by the von Hippel‐Lindau tumour suppressor: implications for cellular oxygen sensing
DR Mole, PH Maxwell, CW Pugh, PJ Ratcliffe
IUBMB life 52 (1), 43-47, 2001
1172001
miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
RI McCormick, C Blick, J Ragoussis, J Schoedel, DR Mole, AC Young, ...
British journal of cancer 108 (5), 1133-1142, 2013
1152013
Extensive regulation of the non‐coding transcriptome by hypoxia: role of HIF in releasing paused RNA pol2
H Choudhry, J Schödel, S Oikonomopoulos, C Camps, S Grampp, ...
EMBO reports 15 (1), 70-76, 2014
1112014
The system can't perform the operation now. Try again later.
Articles 1–20